These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29929789)

  • 1. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells.
    Nakashima Y; Miyagi-Shiohira C; Noguchi H; Omasa T
    Mol Ther; 2018 Jul; 26(7):1715-1734. PubMed ID: 29929789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells.
    Cui P; Zhang P; Zhang Y; Sun L; Cui G; Guo X; Wang H; Zhang X; Shi Y; Yu Z
    FASEB J; 2020 Apr; 34(4):5740-5753. PubMed ID: 32112486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KSCBi005-A-10(hiPSC-HIF1αKO), a HIF1α knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia.
    Han HJ; Kim JH
    Stem Cell Res; 2024 Jun; 77():103415. PubMed ID: 38636267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
    Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
    Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling.
    Haghighi F; Dahlmann J; Nakhaei-Rad S; Lang A; Kutschka I; Zenker M; Kensah G; Piekorz RP; Ahmadian MR
    Cell Commun Signal; 2018 Dec; 16(1):96. PubMed ID: 30518391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.
    Nagashima T; Shimizu K; Matsumoto R; Honda H
    Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
    Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
    Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of histamine/H
    Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
    Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors.
    Hirano K; Nagata S; Yamaguchi S; Nakagawa M; Okita K; Kotera H; Ainscough J; Tada T
    Stem Cells Dev; 2012 May; 21(8):1287-98. PubMed ID: 21882976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between the Efficacy of Cardiac Cell Therapy and the Inhibition of Differentiation of Human iPSC-Derived Nonmyocyte Cardiac Cells Into Myofibroblast-Like Cells.
    Gao L; Yang L; Wang L; Geng Z; Wei Y; Gourley G; Zhang J
    Circ Res; 2018 Dec; 123(12):1313-1325. PubMed ID: 30566050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs).
    Suchorska WM; Augustyniak E; Richter M; Trzeciak T
    Stem Cell Rev Rep; 2017 Apr; 13(2):299-308. PubMed ID: 27987073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
    Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
    PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.